HORMAD1 and lung cancer: Furthermore, the Wnt inhibitor XAV939 impairs HORMAD1 overexpression-induced lung cancer cell motility and EMT, and this effect can be reversed by the Wnt activator CHIR99021 in HORMAD1 knockout (KO) cells.